Novel 2-[(8-hydroxyquinolin-7-yl)(phenyl)methylamino]benzoic acid analogs targeting the active site of botulinum neurotoxins: designing, synthesis, and biological evaluation
- 3 August 2024
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 33 (9) , 1625-1642
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Clinical hematological and biochemical parameters in Swiss, BALB/c, C57BL/6 and B6D2F1 Mus musculusAnimal Models and Experimental Medicine, 2020
- Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type FBioorganic Chemistry, 2019
- Erythrocytes as a biological model for screening of xenobiotics toxicityChemico-Biological Interactions, 2018
- 8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cellsBioorganic & Medicinal Chemistry, 2016
- Derivatives of 8-hydroxyquinoline—antibacterial agents that target intra- and extracellular Gram-negative pathogensBioorganic & Medicinal Chemistry Letters, 2012
- Multifunctional Neuroprotective Derivatives of Rasagiline as Anti-Alzheimer's Disease DrugsNeurotherapeutics, 2009
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial AβNeuron, 2008
- In vitro hemolysis: Guidance for the pharmaceutical scientistJournal of Pharmaceutical Sciences, 2006
- Evidence of steric factors in the fungitoxic mechanisms of 8-quinolinol and its 2-, 3-, 4-, 5-, 6-and 7-chloro and bromo analoguesMonatshefte für Chemie - Chemical Monthly, 1994
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983